Impact of M and E protein mutations in SARS-CoV-2 Omicron variants on reduced antibody binding and increased structural stability: a bioinformatics study (2021-2023).

Publication date: Jul 20, 2026

First identified in late 2021, the Omicron variant of SARS-CoV-2 accumulated substantially more mutations than previously circulating variants. This study investigated the genomic characteristics and structural consequences of mutations in the membrane (M) and envelope (E) proteins of dominant Omicron lineages circulating in southern Iran between March 2021 and March 2023. A total of 528 clinical samples were analyzed using next-generation sequencing (NGS), Nextclade lineage assignment, and complementary bioinformatics approaches. The structural effects of selected mutations were further evaluated using protein-protein docking, PDBe PISA interface analysis, MM/GBSA binding free energy calculations, and 100-ns molecular dynamics simulations. Between 2021 and 2023, BA. 5.2 accounted for 32. 4% of sequenced isolates, whereas XBB. 1.9. 1 became the predominant lineage during the later phase of the study (14. 2%). Structural analysis demonstrated that the interaction interface between the M protein dimer and the Fab fragment remained largely conserved across all investigated variants. However, MM/GBSA calculations revealed mutation-dependent differences in binding energetics, with the BA. 5 (Q19E, A38S, A63T) variant exhibiting the least favorable binding free energy despite preservation of the overall interaction interface. Molecular dynamics simulations further showed that the investigated E protein variants maintained compact conformations with reduced conformational fluctuations relative to the wild-type protein throughout the simulation. Combined genomic surveillance and structural analyses demonstrated that the investigated Omicron-associated mutations largely preserved the overall architecture of the M protein-Fab interaction interface while modulating residue-level energetic contributions and the conformational dynamics of the E protein. These findings indicate that the investigated mutations primarily affect interaction energetics and protein dynamics rather than inducing major structural rearrangements. The integrated computational framework presented in this study provides a useful approach for evaluating the structural consequences of newly emerging SARS-CoV-2 variants and prioritizing mutations for future experimental validation.

Open Access PDF

Concepts Keywords
Envelope
Membrane
Molecular dynamics
Mutation
SARS-CoV-2
Whole genome sequencing

Semantics

Type Source Name
pathway REACTOME Reproduction
disease MESH included
disease MESH Thalassemia
disease MESH Hemoglobinopathy
drug DRUGBANK Coenzyme M
disease MESH cap
pathway KEGG Viral replication
pathway REACTOME Budding
pathway KEGG Virion
pathway REACTOME Release
drug DRUGBANK Amino acids
disease MESH TMD
disease MESH strain
disease MESH COVID 19
drug DRUGBANK Water
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH dissociation
disease MESH PME
disease MESH face
disease MESH hepatitis
drug DRUGBANK Chymotrypsin
drug DRUGBANK L-Cysteine
disease MESH Infection
drug DRUGBANK Guanosine
disease MESH severe acute respiratory syndrome
pathway REACTOME Autophagy
disease MESH Chai

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *